Shanghai Allist Pharmaceuticals Co. Ltd. Class ASSE: 688578

Announcement on Voluntary Disclosure of Obtaining the Drug Clinical Trial Approval Notification for AST2303 Tablets

· Issued by Shanghai Allist Pharmaceuticals Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Obtaining the Drug Clinical Trial Approval Notification for AST2303 Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment